Gillian C. Ivers-Read
2013
In 2013, Gillian C. Ivers-Read earned a total compensation of $1.6M as EVP of Technical Operations and Chief Regulatory Officer at Clovis Oncology, a 28% increase compared to previous year.
Compensation breakdown
| Bonus | $222,780 |
|---|---|
| Option Awards | $1,018,433 |
| Salary | $369,500 |
| Other | $26,142 |
| Total | $1,636,855 |
Ivers-Read received $1M in option awards, accounting for 62% of the total pay in 2013.
Ivers-Read also received $222.8K in bonus, $369.5K in salary and $26.1K in other compensation.
Rankings
In 2013, Gillian C. Ivers-Read's compensation ranked 4,592nd out of 12,286 executives tracked by ExecPay. In other words, Ivers-Read earned more than 62.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,592 out of 12,286 | 63rd |
Division Manufacturing | 1,569 out of 4,612 | 66th |
Major group Chemicals And Allied Products | 452 out of 1,462 | 69th |
Industry group Drugs | 315 out of 1,156 | 73rd |
Industry Pharmaceutical Preparations | 254 out of 890 | 72nd |
Source: SEC filing on April 27, 2016.
Ivers-Read's colleagues
We found four more compensation records of executives who worked with Gillian C. Ivers-Read at Clovis Oncology in 2013.
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019